ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NRx Pharmaceuticals’ Zyesami yields positive data in EAP for Covid-19
June 17, 2021NRx Pharmaceuticals has reported positive results from the expanded access protocol (EAP) of its Zyesami (Aviptadil) in critical Covid-19 patients admitted to the ICU with respiratory failure. -
BrainStorm Announces NurOwn Expanded Access Program
January 05, 2021BrainStorm Cell Therapeutics has announced the initiation of a NurOwn® (MSC-NTF cells) Expanded Access Program (EAP) for patients with amyotrophic lateral sclerosis (ALS) who completed the Company's recently concluded pivotal Phase 3 clinical trial ... -
Expanded access for compassionate use of remestemcel-L in COVID-19 infected children
July 08, 2020US expands access to remestemcel-L for compassionate use in COVID-19 infected children with complications of multisystem inflammatory syndrome.
Pharma Sources Insight January 2025
